Using data from 1991 to 2000, the authors estimated that 886,202 deaths could have been averted had the death rate of African Americans and whites been comparable during this time period. The authors calculated that technological advances during those years averted 176,633 deaths.
The authors explained that it would take years to fully determine the differences in the benefits of the two approaches, but pointed out that policy-makers need some guidance now. Because a five-fold difference in averted deaths was observed, the researchers stated that more precise calculations would be unlikely to change the direction of their findings.
"The prudence of investing billions in the development of new drugs and technologies while investing only a fraction of that amount in the correction of disparities deserves reconsideration. It is an imbalance that may claim more lives than it saves," concluded the researchers.
The authors include Steven H. Woolf, M.D., lead author and professor of family medicine, preventive medicine and community health at Virginia Commonwealth University (VCU), Richmond; David Satcher, M.D., Ph.D., director of the National Center for Primary Care at Morehouse School of Medicine, Atlanta, and former U.S. surgeon general; Robert E. Johnson, Ph.D., associate professor of biostatistics at VCU; George E. Fryer Jr., Ph.D., formerly an analyst with the Robert Graham Center: Policy Studies in Family Medicine and Primary Care in Washington, D.C., and George Rust, MD, deputy director of the National Center for Primary Care.